Evidence map›Paper›PMID 26880555›Full record

ArticleeLife2016

Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity.

Prithvi Raj, Ekta Rai, Ran Song, Shaheen Khan, Benjamin E Wakeland, Kasthuribai Viswanathan, Carlos Arana, Chaoying Liang, Bo Zhang, Igor Dozmorov and 19 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 135 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. HLA-DQB1*03:01 strongly affects age of onset of type 1 narcolepsy independently of DQA1 and ethnicity.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Genetic haplotypes inJournal for immunotherapy of cancer · 2025
    Article
  9. A haplotype-resolved view of human gene regulation.bioRxiv : the preprint server for biology · 2025
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 11 institutions in 3 countries.

Prithvi RajDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
Ekta RaiDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
Ran SongDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
Shaheen KhanDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
Benjamin E WakelandDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
Kasthuribai ViswanathanDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
Carlos AranaDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
Chaoying LiangDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
Bo ZhangDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
Igor DozmorovDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
Ferdicia Carr-JohnsonDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
Mitja MitrovicDepartment of Neurology, Yale School of Medicine, New Haven, United States.
Graham B WileyArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States.
Jennifer A KellyArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States.
Bernard R LauwerysPole de pathologies rhumatismales, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Bruxelles, Belgium.
Nancy J OlsenDivision of Rheumatology, Department of Medicine, Penn State Medical School, Hershey, United States.
Chris CotsapasDepartment of Neurology, Yale School of Medicine, New Haven, United States.
Christine K GarciaDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, United States.
Carol A WiseEugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, United States.
John B HarleyCincinnati VA Medical Center, Cincinnati, United States.
Swapan K NathArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States.
Judith A JamesArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States.
Chaim O JacobDepartment of Medicine, University of Southern California, Los Angeles, United States.
Betty P TsaoDepartment of Medicine, University of California, Los Angeles, Los Angeles, United States.
Chandrashekhar PasareDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
David R KarpRheumatic Diseases Division, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, United States.
Quan Zhen LiDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.
Patrick M GaffneyArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States.
Edward K WakelandDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, United States.ORCID http://orcid.org/0000-0002-7107-0992
The University of Texas Southwestern Medical Center · USOklahoma Medical Research Foundation · USYale University · USCincinnati Children's Hospital Medical Center · USPenn State Milton S. Hershey Medical Center · USShri Mata Vaishno Devi University · INSouthwestern Medical Center · USTexas Scottish Rite Hospital for Children · USUCLouvain · BEUniversity of California, Los Angeles · USUniversity of Southern California · US

Funding

Tracking and Evaluation CoreU54GM104938 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Robert Hal Scofield · 2013 to 2026
$68.2M
SLAM Genes-from Mouse to ManP50AR055503 · NIAMS · UT SOUTHWESTERN MEDICAL CENTER · PI OLSEN, NANCY J · 2007 to 2011
$8.3M
HLA GENE COMPLEMENTATION IN PRIMARY SJOGREN'S AND LUPUSR01AI024717 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI KOTTYAN, LEAH CLAIRE, WEIRAUCH, MATTHEW TYSON · 1987 to 2025
$7.8M
SNP Confirmation and High Throughput Genotyping CoreP30AR053483 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GUTHRIDGE, JOEL MARVIN · 2007 to 2017
$6.7M
Pre-Clinical Studies to Identify SLE Therapeutic TargetsU19AI082714 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GAFFNEY, PATRICK M · 2009 to 2018
$6.2M
Quantitative Analysis Core P30GM110766 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GAFFNEY, PATRICK M · 2014 to 2018
$6.1M
Candidate Causal Variants in Systemic Lupus ErythematosusRC2AR058959 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GAFFNEY, PATRICK M, WAKELAND, EDWARD K. · 2009 to 2010
$4.3M
Genetic Pathways Contributing to Systemic Lupus Erythematosus PathogenesisR37AI045196 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI WAKELAND, EDWARD K. · 2003 to 2012
$4.0M
Science in a Culture of MentoringP30GM103510 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JAMES, JUDITH A · 2012 to 2016
$3.9M
SLE Susceptibility and Clinical Significance at 2q22-24 across Multiple EthnicitiR01AR060366 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI NATH, SWAPAN K. · 2010 to 2019
$3.3M
Understanding early events in lupus autoimmunity to aid preventionU01AI101934 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JAMES, JUDITH A · 2012 to 2016
$2.3M
Functional Mechanisms of Causal Variants in Systemic Lupus ErythematosusR01AR063124 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GAFFNEY, PATRICK M · 2012 to 2016
$2.0M
NIAID NIH HHS R01 AI024717NIAID NIH HHS R01 AI045196NIAID NIH HHS R37 AI045196NIAID NIH HHS U01 AI101934NIAID NIH HHS U19 AI082714NIAMS NIH HHS P30 AR053483NIAMS NIH HHS P50 AR055503NIAMS NIH HHS R01 AR060366NIAMS NIH HHS R01 AR063124NIAMS NIH HHS RC2 AR058959NIGMS NIH HHS P30 GM103510NIGMS NIH HHS P30 GM110766NIGMS NIH HHS U54 GM104938
6 · The paper itself

Abstract

Targeted sequencing of sixteen SLE risk loci among 1349 Caucasian cases and controls produced a comprehensive dataset of the variations causing susceptibility to systemic lupus erythematosus (SLE). Two independent disease association signals in the HLA-D region identified two regulatory regions containing 3562 polymorphisms that modified thirty-seven transcription factor binding sites. These extensive functional variations are a new and potent facet of HLA polymorphism. Variations modifying the consensus binding motifs of IRF4 and CTCF in the XL9 regulatory complex modified the transcription of HLA-DRB1, HLA-DQA1 and HLA-DQB1 in a chromosome-specific manner, resulting in a 2.5-fold increase in the surface expression of HLA-DR and DQ molecules on dendritic cells with SLE risk genotypes, which increases to over 4-fold after stimulation. Similar analyses of fifteen other SLE risk loci identified 1206 functional variants tightly linked with disease-associated SNPs and demonstrated that common disease alleles contain multiple causal variants modulating multiple immune system genes.

Indexed as

AutoimmunityGene Expression RegulationPolymorphism, GeneticDendritic CellsEuropeHLA-D AntigensHumansLupus Erythematosus, SystemicMembrane ProteinsUnited StatesWhite PeopleHLA-D AntigensMembrane Proteinsevolutionary biologygenomicshaplotypeHLAhumanhuman biologyLDmedicinerisk alleleSLE risktargeted sequencing

Identifiers

PMID26880555
PMCPMC4811771
OpenAlexW2293423772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.